Learn more about TD2’s comprehensive immuno-oncology research platform

TD2 offers a comprehensive panel of human and murine tumor models for adoptive cell therapy and immuno-oncology drug development.

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content